The positives are, we remain debt free.
As long as the funds are used to bring value to the company's cashflows, then I'd prefer CR over debt because the company will yield better NPATs each year, which translate to higher EPS and P/E.
CRs only hurts shareholders short term.
- Forums
- ASX - By Stock
- SYA
- Ann: Trading Halt
Ann: Trading Halt, page-143
-
-
- There are more pages in this discussion • 247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $344.8M |
Open | High | Low | Value | Volume |
3.4¢ | 3.6¢ | 3.3¢ | $1.369M | 39.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
72 | 25281049 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 2185907 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
72 | 25281049 | 0.033 |
189 | 45743490 | 0.032 |
61 | 11743210 | 0.031 |
105 | 16172427 | 0.030 |
27 | 5292394 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 2185907 | 13 |
0.035 | 3958066 | 13 |
0.036 | 7811520 | 30 |
0.037 | 7675044 | 26 |
0.038 | 4107914 | 19 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SYA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online